cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results
Rhea-AI Summary
cbdMD (NYSE American: YCBD), a leading CBD company, has scheduled a conference call to discuss its Q3 FY2025 financial results for the period ending June 30, 2025. The call will take place on Thursday, August 14, 2025, at 4:20 p.m. Eastern Time.
Investors can access the call through multiple channels including USA/Canada (833-821-3524) and International (647-846-2919) dial-in numbers. A replay will be available with passcode 5327882, and the webcast replay will remain accessible through August 15, 2026, via the provided link.
Positive
- None.
Negative
- None.
News Market Reaction 3 Alerts
On the day this news was published, YCBD declined 2.80%, reflecting a moderate negative market reaction. Argus tracked a trough of -14.7% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $249K from the company's valuation, bringing the market cap to $9M at that time. Trading volume was elevated at 2.7x the daily average, suggesting increased selling activity.
Data tracked by StockTitan Argus on the day of publication.
Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.
CONFERENCE CALL DETAILS
| Thursday, August 14, 2025, 4:20 p.m. Eastern Time | |
| USA/Canada: | 833-821-3524 |
| International: | 647-846-2919 |
| Teleconference Replay dial in: | |
| USA/Canada: | 855-669-9658 |
| International: | 412-317-0088 |
| Replay Passcode: | 5327882 |
| Webcast/Webcast Replay link - available through August 15, 2026 | |
| https://www.gowebcasting.com/14151 |
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262184
FAQ
When is cbdMD's Q3 2025 earnings call scheduled?
How can investors access cbdMD's Q3 2025 earnings call?
How long will cbdMD's Q3 2025 earnings call replay be available?
What period will cbdMD's earnings call cover?
